Competitive Technologies (CTTC) has entered into a strategic marketing agreement to sell New York-based BiCOM’s patented products in the US and across various international markets.
BiCOM’s main product line includes Diaton tonometer which allows eye care and medical professionals to measure intraocular pressure (IOP) for glaucoma through the eyelid, without anesthesia and direct contact with the eyeball.
BiCOM’s Magnetic Therapy Diaton unit makes use of the fact that certain types of magnetism with low-intensity are capable of performing general therapeutic and curative functions.
Internationally, CTTC will market BiCOM’s Magnetic Therapy DIATON for magnetic therapy.
CTTC will offer BiCOM’s Diaton tonometer, developed and manufactured in Russia, in the US and international markets.
CTTC EVP Aris Despo said they also anticipate BiCOM working with the company to expand the Calmare Scrambler to Russia and other foreign markets where they already have established distribution for BiCOM products.
CTTC is the licensed worldwide distributor of the non-invasive Calmare pain therapy medical device, which incorporates the biophysical ‘Scrambler Therapy’ technology developed in Italy by CTTC’s client, Professor Giuseppe Marineo to treat neuropathic pain, including cancer pain.